Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

@article{Micha2011SystematicRA,
  title={Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.},
  author={Renata Micha and Fumiaki Imamura and Moritz C. Wyler von Ballmoos and Daniel H. Solomon and Miguel A. Hern{\'a}n and Paul M. Ridker and Dariush Mozaffarian},
  journal={The American journal of cardiology},
  year={2011},
  volume={108 9},
  pages={
          1362-70
        }
}
Inflammation predicts risk for cardiovascular disease (CVD) events, but the relation of drugs that directly target inflammation with CVD risk is not established. Methotrexate is a disease-modifying antirheumatic drug broadly used for the treatment of chronic inflammatory disorders. A systematic review and meta-analysis of evidence of relations of methotrexate with CVD occurrence were performed. Cohorts, case-control studies, and randomized trials were included if they reported associations… CONTINUE READING
Highly Cited
This paper has 188 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 86 extracted citations

188 Citations

02040'13'15'17'19
Citations per Year
Semantic Scholar estimates that this publication has 188 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.

Systematic review and meta - analysis of methotrexate use and risk of cardiovascular disease

DH Solomon, MA Hernán, D Mozaffarian
-1